Utilization of RapidFACT® strategies to evaluate and develop an In Vitro - In Vivo Correlation (IVIVC) for Modified Release Formulations of Lorcaserin HCl

A RapidFACT® study was conducted to identify and optimize an MR formulation of lorcaserin. This presentation describes the clinical processes and data analyses involved in establishing an IVIVC for a series of prototype MR lorcaserin formulations. 

The slowest release rate formulation was selected for further development.